BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33716628)

  • 1. The Clinical and Molecular Characteristics of Sex-Determining Region Y-Box 2 and its Prognostic Value in Breast Cancer: A Systematic Meta-Analysis.
    Zhao G; Wang X; Qu L; Zhu Z; Hong J; Hou H; Li Z; Wang J; Lv Z
    Breast Care (Basel); 2021 Feb; 16(1):16-26. PubMed ID: 33716628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of Sox2 expression in patients with breast cancer: a meta-analysis.
    Zheng Y; Qin B; Li F; Xu S; Wang S; Li L
    Int J Clin Exp Med; 2015; 8(12):22382-92. PubMed ID: 26885218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Survival Impact of Sex-Determining Region Y-Box 2 in Colorectal Cancer: An Integrated Analysis of the Immunohistochemical Study and Bioinformatics Analysis.
    Song K; Hao J; Ge Z; Chen P
    J Oncol; 2020; 2020():3761535. PubMed ID: 32104175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
    Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
    Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX2 as a prognostic marker and a potential molecular target in cervical cancer: A meta-analysis.
    Yuan D; Wang J; Yan M; Xu Y
    Int J Biol Markers; 2021 Dec; 36(4):45-53. PubMed ID: 34719977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
    Qiao W; Liu H; Guo W; Li P; Deng M
    Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and clinicopathological significance of fatty acid synthase in breast cancer: A systematic review and meta-analysis.
    Liu B; Peng Q; Wang YW; Qiu J; Zhu J; Ma R
    Front Oncol; 2023; 13():1153076. PubMed ID: 37124526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX2 contributes to invasion and poor prognosis of gastric cancer: A meta-analysis.
    Tang K; Liu J; Liu B; Meng C; Liao J
    Medicine (Baltimore); 2022 Sep; 101(36):e30559. PubMed ID: 36086709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and clinical significance of focal adhesion kinase expression in breast cancer: A systematic review and meta-analysis.
    Qiao W; Wang W; Liu H; Guo W; Li P; Deng M
    Transl Oncol; 2020 Nov; 13(11):100835. PubMed ID: 32702646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and clinical significance of histone deacetylase 1 expression in breast cancer: A meta-analysis.
    Qiao W; Liu H; Liu R; Liu Q; Zhang T; Guo W; Li P; Deng M
    Clin Chim Acta; 2018 Aug; 483():209-215. PubMed ID: 29738697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
    Gao ZH; Li CX; Liu M; Jiang JY
    BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis.
    Li Z; Yin S; Zhang L; Liu W; Chen B; Xing H
    Onco Targets Ther; 2017; 10():859-870. PubMed ID: 28243121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis.
    Zhang Z; Fang T; Lv Y
    World J Surg Oncol; 2022 Nov; 20(1):361. PubMed ID: 36372891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of SOX2 in head and neck cancer: a meta-analysis.
    Dong Z; Liu G; Huang B; Sun J; Wu D
    Int J Clin Exp Med; 2014; 7(12):5010-20. PubMed ID: 25664000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of sex-determining region Y-box 30 with tumor characteristics and its prognostic value in breast cancer.
    Peng H; Luo Y; Wu J; Yin W
    J Clin Lab Anal; 2020 Jun; 34(6):e23232. PubMed ID: 32157740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
    Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
    PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfavorable Prognostic Effects of the Stem Cell Pluripotency Factor Sox2 in Feline Invasive Mammary Carcinomas.
    Truchot Y; Dagher E; Abadie J; Nguyen F
    Front Vet Sci; 2020; 7():622019. PubMed ID: 33553286
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis.
    Gonzalez-Conchas GA; Rodriguez-Romo L; Hernandez-Barajas D; Gonzalez-Guerrero JF; Rodriguez-Fernandez IA; Verdines-Perez A; Templeton AJ; Ocana A; Seruga B; Tannock IF; Amir E; Vera-Badillo FE
    Cancer Treat Rev; 2018 Jan; 62():1-8. PubMed ID: 29126017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.